Zobrazeno 1 - 10
of 84
pro vyhledávání: '"T, Mongkolsuk"'
Autor:
Nuttapon Arpornsujaritkun, D. Thammanichanond, P Kantachuvesiri, Sasivimol Rattanasiri, P Tipjaiaue, Atiporn Ingsathit, Surasak Kantachuvesiri, T. Mongkolsuk, Vasant Sumethkul
Publikováno v:
Transplantation Proceedings. 49:1249-1255
Background Sensitization is associated with a high rate of post-transplantation rejection. A desensitization protocol using therapeutic plasma exchange (TPE) was proposed to reduce anti-HLA antibody before transplantation, but there has been limited
Autor:
S.A. Vallipakorn, T. Mongkolsuk, Surasak Kantachuvesiri, Suchin Worawichawong, D. Thammanichanond, P. Wiwattanathum, Pimpun Kitpoka
Publikováno v:
Transplantation Proceedings. 48:756-760
Background Kidney transplant recipients who have pretransplant donor-specific human leukocyte antigen (HLA) antibodies have greater risk for developing allograft rejection and allograft loss. However, there is a varied effect of graft injury among pa
Publikováno v:
Transplantation Proceedings. 48:761-765
Background The impact of specific HLA antibodies on the allograft function in the Luminex era is not clearly known. This study aimed to investigate kidney transplantation outcomes in patients with different anti-HLA antibody status as detected by Lum
Autor:
Pimpun Kitpoka, D. Thammanichanond, W. Parapiboon, T. Mongkolsuk, Chutima Tammakorn, Suchin Worawichawong
Publikováno v:
Transplantation proceedings. 50(8)
The presence of isolated de novo anti-DP antibodies is uncommon, making it difficult to determine the impact of anti-DP antibodies on graft outcome. We describe a case of acute antibody-mediated rejection mediated by de novo donor-specific anti-HLA-D
Autor:
Sopon Jirasiritham, T. Mongkolsuk, D. Thammanichanond, Atiporn Ingsathit, Suchin Worawichawong, Pimpun Kitpoka
Publikováno v:
Transplantation Proceedings. 46:644-647
HLA antibodies usually recognize epitopes rather than antigens. This case report reveals that acute antibody-mediated rejection (AMR) that occurred in a kidney transplant recipient with low-level donor-specific antibodies (DSAs) could be explained by
Autor:
Pimpun Kitpoka, W. Athimang, Surasak Kantachuvesiri, Atiporn Ingsathit, K. Paisooksantivatana, T. Mongkolsuk, Suchin Worawichawong, D. Thammanichanond, Sopon Jirasiritham
Publikováno v:
Transplantation Proceedings. 44:62-65
Objectives The complement-dependent lymphocytotoxicity crossmatch (CDC-XM) detects cytotoxic parameters of preformed antibodies. The flow cytometric crossmatch (FCXM) is used to detect the binding of recipient antibodies to donor cells. Because these
Publikováno v:
Transplantation proceedings. 48(3)
Background The presence of donor-specific human leukocyte antigen antibodies (HLA-DSA) can be determined by performing Luminex assay with single-antigen beads. The single-antigen beads' panels cover the most frequent HLA alleles of the HLA-A, B, C, D
Autor:
D. Thammanichanond, T. Mongkolsuk, Suwit Chaisri, Chutima Tammakorn, Pimpun Kitpoka, Chanvit Leelayuwat
Publikováno v:
Human immunology. 77(6)
Killer-cell immunoglobulin-like receptors (KIRs) play an important role in natural killer (NK) cell regulation. Interaction of KIRs with human leukocyte antigen (HLA) class I molecules can transmit signals to regulate the function of NK cells. In thi
Autor:
D. Thammanichanond, Atiporn Ingsathit, Jatupon Krongvorakul, T. Mongkolsuk, Surasak Kantachuvesiri, Pimpun Kitpoka, Sasivimol Rattanasiri
Publikováno v:
Asian Pacific journal of allergy and immunology. 33(2)
Background: Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule that displays strong immune-inhibitory properties and has been associated with allograft acceptance. However, there are conflicting data on the correlation of soluble
Autor:
T. Mongkolsuk, Suchin Worawichawong, Sasivimol Rattanasiri, D. Thammanichanond, Pimpun Kitpoka, Sopon Jirasiritham, Surasak Kantachuvesiri
Publikováno v:
Transplantation proceedings. 46(2)
Objectives De novo donor-specific HLA antibodies (DSA) are associated with allograft rejection and allograft loss. However, not all DSA are equally detrimental to allograft function. The ability to activate complement may be an important factor diffe